With the increasing amount of available data, AI and machine learning have emerged as crucial tools for biopharmaceutical companies looking to remain competitive in the market. These tools are helping ...

Last year, the biotechnology industry celebrated the twentieth anniversary of the approval of the first true product of modern biotechnology—recombinant insulin (Humulin; Genentech, S. San Francisco, ...

Modern technologies, including Industry 4.0 and the Industrial Internet of Things, offer opportunities to increase biopharmaceutical manufacturing efficiency. Biopharmaceutical manufacturing companies ...

Biopharmaceuticals, also known as biologics, are a class of medicines produced using living systems such as microorganisms, plant or animal cells, or recombinant DNA technology. Unlike traditional ...

Using plant cells to make biopharmaceuticals is not a new idea. Pfizer’s Gaucher disease drug Elelyso (taliglucerase alfa), which is manufactured using carrot cells in culture—was approved in 2012.

Since 2003, BioPlan Associates, Inc. has published an extensive annual survey of bioprocessing professionals. Since the first survey, which was started in collaboration with the American Society for ...